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LIPASE SEBAGAI PEMANGKIN DALAM SINTESIS ESTER ASID 
KAFFEIK BORNIL 
 
ABSTRAK 
 
Ester asid kaffeik bornil (EAKB) berasaskan asid kaffeik merupakan produk 
semulajadi yang jarang ditemui serta mempunyai sifat biologi dan farmakologi yang 
signifikan. Walaubagaimanapun, penggunaan cara tradisional seperti pengekstrakan 
dan sintesis menggunakan bahan kimia bagi menghasilkan sebatian ini memerlukan 
kos yang tinggi, kurang cekap dan toksik kepada manusia dan alam sekitar. Oleh itu, 
objektif utama kajian ini adalah untuk memperkenalkan tindak balas hijau bagi 
menghasilkan EAKB menggunakan enzim lipase sebagai pemangkin dalam tindak 
balas transesterifikasi. Sintesis EAKB telah dijalankan dengan melakukan 
pemeriksaan awal ke atas beberapa pemboleh ubah tindak balas penting seperti 
pelbagai jenis enzim disekat gerak (Novozym 435, Lipozyme TLIM and Lipozyme 
RMIM), pelarut organik (isooctane, n-hexane, n-heptane, toluene, acetone, 
acetonitrile, n-hexane:diethyl ether and n-hexane:acetone) dan jenis kumpulan alkil 
yang digunakan (metil kaffeat and etil kaffeat) diikuti dengan mengkaji kesan 
pemboleh ubah tindak balas seperti jumlah enzim (25 – 250 U), masa tindak balas (0 
– 84 h), nisbah substrat borneol kepada etil kaffeat (1:1, 1.5:1, 2:1, 2.5:1 and 3:1), 
suhu tindak balas (30 - 60°C) dan keadaan tindak balas optimum menggunakan 
kaedah tradisional satu faktor dalam satu masa untuk mendapatkan respon tertinggi. 
Mekanisma kinetik telah dikaji dan pemalar kinetik telah ditentukan berdasarkan 
kadar tindak balas awal yang diperoleh daripada penyiasatan ke atas kesan kepekatan 
substrat. Pengoptimuman bagi penghasilan EAKB juga telah dijalankan dengan 
menggunakan kaedah tindak balas permukaan dengan reka bentuk “face-centered 
central composite design (CCD)” bagi mendapatkan respon tertinggi. Akhir sekali, 
xvi 
 
tenaga pengaktifan yang diperlukan untuk tindak balas telah ditentukan dengan 
menjalankan tindak balas transesterifikasi pada pelbagai suhu dari 30°C sehingga 
55°C. Hasil daripada pemeriksaan awal yang telah dijalankan, Novozym 435 telah 
didapati memberikan pertukaran tertinggi diikuti oleh enzim Lipozyme TLIM dan 
enzim Lipozyme RMIM. Pertukaran substrat tertinggi juga telah diperolehi dengan 
menggunakan sistem pelarut campuran (n-hexane:acetone, 80:20, % isipadu/isipadu) 
dan etil kaffeat sebagai substrat. Berdasarkan kajian ke atas pemboleh ubah tindak 
balas menggunakan kaedah satu faktor dalam satu masa, pertukaran tertinggi telah 
diperoleh dengan menggunakan unit enzim sebanyak 125 U dan masa tindak balas 
selama 48 jam pada suhu 55°C. Nisbah substrat borneol kepada etil kaffeat 2.5:1 (25 
mM borneol: 10 mM EC) telah diperhatikan menghasilkan peratusan pertukaran 
tertinggi. Pada keadaan tindak balas optimum seperti yang telah dinyatakan di atas, 
peratusan pertukaran substrat tertinggi telah diperoleh iaitu sebanyak 86.0%. Model 
kinetik bagi tindak balas sintesis EAKB menggunakan enzim lipase Novozym 435 
telah didapati mematuhi mekanisme kompleks ternari dan pemalar kinetik adalah 
seperti berikut; KmEC = 0.091 mM, KmBor = 10.908 mM, Vmax = 0.187 mM/min and 
KiBor = 1.943 mM. Keadaan optimum yang telah dicadangkan oleh kaedah tindak 
balas permukaan dengan rekabentuk “face-centered central composite design (CCD)” 
pula adalah menggunakan jumlah enzim sebanyak 245 U dalam tempoh selama 36 
jam dan suhu 60°C untuk menghasilkan kadar pertukaran substrat optimum sebanyak 
93.64%. Anggaran bagi tenaga pengaktifan yang diperlukan oleh lipase Novozym 
435 untuk sintesis EAKB adalah 57.6 kJ/mol.  
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LIPASE-CATALYZED SYNTHESIS OF CAFFEIC ACID BORNYL ESTER 
 
ABSTRACT 
 
Caffeic acid bornyl ester (CABE) is a rare caffeic acid derivative and natural 
product with significant biological and pharmacological properties. However, the use 
of traditional chemical extraction and chemical synthesis method to produce CABE 
are uneconomical, inefficient and toxic to human and environment. Thus, the main 
objective of this study is to establish a green reaction pathway for the synthesis of 
CABE via lipase-catalyzed transesterification reaction. The synthesis of CABE was 
conducted by the screening of important parameters such as types of immobilized 
enzyme (Novozym 435, Lipozyme TLIM and Lipozyme RMIM), organic solvents 
(isooctane, n-hexane, n-heptane, toluene and n-hexane:acetone) and effect of alkyl 
group (methyl caffeate and ethyl caffeate) followed by investigating the effect of 
reaction parameters such as enzyme loading (25 – 250 U), reaction time (0 – 84 h), 
substrate ratio of borneol to ethyl caffeate (1:1, 1.5:1, 2:1, 2.5:1 and 3:1), reaction 
temperature (30 – 60°C) and optimum reaction conditions based on traditional one 
factor at a time (OFAT) method. The reaction kinetic mechanism was investigated 
and kinetic parameters of lipase-catalyzed transesterification reaction were 
determined based on the initial reaction rate obtained from the investigation of the 
effect of substrates concentration. The optimization of CABE production was also 
conducted using response surface methodology (RSM) based on face-centered 
central composite design (CCD) to obtain the highest response. Finally, the activation 
energy required for the reaction was determined by conducting the transesterification 
reaction at various temperatures from 30°C to 55°C. From the screening, it was 
found that Novozym 435 gave the highest conversion followed by Lipozyme TLIM 
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and Lipozyme RMIM. The highest substrate conversion was obtained using mixed 
solvents system (n-hexane:acetone, 80:20, %v/v) and ethyl caffeate as substrate. In 
the investigation of effect of reaction parameters based on OFAT method, the highest 
conversions were obtained by using 125 U of enzyme loading, 48 h of reaction time 
and temperature at 55°C. It was observed that the substrate ratio of borneol to EC, 
2.5:1 (25 mM borneol: 10 mM EC) resulted in the highest conversion. At the 
selected optimum reaction conditions as described above, the highest substrate 
conversion of 86.0% was obtained. The reaction kinetics model for CABE synthesis 
using lipase Novozym 435 was found to obey the ternary complex mechanism and 
the kinetic parameters were as follows; KmEC = 0.091 mM, KmBor = 10.908 mM, 
Vmax = 0.187 mM/min and KiBor = 1.943 mM. The optimized condition suggested by 
RSM was found to be 245 U of enzyme loading at 36 h and 60°C with 93.64% 
conversion. The estimated activation energy value of lipase Novozym 435 for the 
synthesis of CABE was observed to be 57.6 kJ/mol. 
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CHAPTER ONE 
INTRODUCTION 
 
In this chapter, the background of research is briefly described starting with 
the importance of natural products followed by the introduction of caffeic acid bornyl 
ester potential as natural product and how it is currently being synthesized. Then, a 
brief outline of enzymatic-catalyzed synthesis as a promising alternative method is 
highlighted followed by the problem statement, objectives and scope of the study. 
 
1.1 Natural products in pharmaceutical industry  
Natural products (NPs), also known as secondary metabolites have been used 
widely since ancient times as a treatment to various diseases and illnesses. One of the 
earliest evidence on the use of natural products was the clay tablets from 
Mesopotamia (2600 B.C). A record from Egypt, namely The Ebers Papyrus (2900 
B.C.) reported the used of about 700 natural product-based drugs such as pills, 
ointments and infusions (David et al., 2014). A large numbers of medicinal drugs 
from ancient China have been documented in the Chinese Materia Medica. Among 
the records are the Shennong Herbal (100 B.C.) with 365 drugs documented and the 
Tang Herbal (659 A.D.) which reported the used of 850 natural-based drugs (Cragg 
& Newman, 2005).  
 
Nowadays, the roles of NPs in drug discovery and development have been 
remarkable. Almost half of the pharmaceuticals today are inspired by NPs. It was 
estimated that about 25 % to 50% of current drugs present in the market owe their 
origins to NPs (David et al., 2014). This fact was supported by the statistics 
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presented by Newman and Cragg in 2012 (Figure 1.1). Analysis by Newman and his 
coworker from 1981 to 2010 revealed that NPs have been among important sources 
of new drugs and played significant roles in the therapeutic treatment of cancer and 
anti-hypertensive disease.  
 
 
Figure 1.1: Approved drugs from 1981 to 2010 (Newman & Cragg, 2012) 
 
As shown in Figure 1.1, 29 % of drugs approved were of synthetic origin 
while the remaining was derived from NPs, natural product mimics, having 
pharmacophore from NPs, vaccine and biological products. These data indicated the 
influence of products other than formal synthetic products in the discovery and 
approval of new drug (Newman & Cragg, 2012). Another evidence of NPs influence 
can be seen in year 2000, 2001 and 2003, in which the sales of NP-derived drugs was 
ranked in the top 35 over the total sales of ethical drugs worldwide. In 1998 to 2004, 
the launching of 21 NPs and NP-derived drugs had been successfully launched in the 
United States, Europe and Japan market (Butler, 2005).  
 
Synthetic, 29% 
Natural 
derived 
products, 
22% 
Biological, 
15% 
Synthetic, 
natural mimics, 
11% 
Synthetic but 
pharmacophore 
from NPs, 
natural mimics, 
9% 
Vaccine, 6% Synthetic but 
pharmacophore 
from NPs, 4% 
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1.2 The properties of natural products 
Since a long time, NPs have undoubtedly being important sources of new 
drugs in the process to develop novel medicinal compounds for various treatments. 
The diversity of NPs in the nature from all over the world has been one of the 
important characters for them to serve as unlimited sources of novel lead compounds. 
It was estimated that only 5 to 15 % out of 250,000 species of vascular plants (higher 
plants) have been extensively investigated. Also, unlimited sources of natural 
products from microorganisms provide potential novel compounds especially with 
the advanced in genetic engineering (Cragg & Newman, 2005). In addition, most of 
NPs contain several bio-active components which are responsible for various 
beneficial properties such as biological and pharmacological activities, flavors, 
nutritional values and preservation activities (David et al., 2014; Amirkia & Heinrich, 
2015).  
   
Among the natural products that have gained researchers interest in the last 
few years is the caffeic acid (3,4-dihydroxycinnamic acid) and its derivatives or 
analogs. Caffeic acid (CA) can be found widely in human diet and nature including 
wide variety of plants such as coffee, wine, fruits and vegetables (Wang et al., 2008). 
Extensive studies on caffeic acid from the past few years had revealed their potential 
biological and pharmacological properties. Among significant properties of CA are 
antioxidant (Sroka & Cisowski, 2003), antibacterial (Tsou et al., 2000), anticancer, 
anti-inflammatory and antiviral activities (Wang et al., 2008). Due to the remarkable 
properties present, CA could serve as a potential lead compound for the development 
of new drugs. 
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Caffeic acid phenethyl ester (CAPE) is one of the most popular CA 
derivatives. A lot of studies have been conducted to explore CAPE properties and 
extensive efforts have been made to synthesize them more efficiently. CAPE is a 
bio-active compound found in honeybee propolis extracts with numerous biological 
and pharmacological properties such as anti-inflammatory (Gu et al., 2014), 
antioxidants (LeBlanc et al., 2012), anti-metastatic (Liao et al., 2003), anticancer 
(Ozturk et al., 2012) and antiviral activity (Erdemli, 2015). The chemical structure of 
CAPE consists of hydroxyl group inside catechol ring which is responsible for 
various biological and pharmacological activities of this compound (Murtaza et al., 
2014).  
 
1.3 The properties, extraction and synthesis of caffeic acid bornyl ester  
Besides CAPE, another CA derivative that has gained researchers interest 
lately is the caffeic acid bornyl ester (CABE). However, there is lack of extensive 
study to improve the synthesis of CABE compared to CAPE. CABE or also known 
as bornyl caffeate was initially extracted and isolated from plants. CABE was first 
isolated by Maldonado et al. (1998) from a plant namely Coreopsis mutica var. 
mutica and was identified to exhibit anti-inflammatory activity. In the next year, 
CABE was isolated from Piper caninum and was found to show high antibacterial 
activity against a wide range of bacteria (Setzer et al., 1999). The extraction of Piper 
philippinum and Verbesina turbacensis Kunth led to the isolation of several 
compounds including CABE (Chen et al., 2007; Ogungbe et al., 2010). The synthesis 
of CABE via one-pot method was conducted by Xia et al. (2008) and it was found 
that CABE had the ability to inhibit HIV integrase. CABE had also been found to 
show high potential in anticancer property. Based on a study by Yang et al. (2014), it 
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was found that CABE had demonstrated the ability in activating the intracellular 
reactive oxygen sprecies (ROS)- and c-Jun N-terminal kinase (JNK)- mediated 
pathways and thus inducing apoptosis in the human breast cancer MCF-7 cells. In a 
recent study by Glaser et al. (2014), the extraction of Valeriana wallichii (V. wallichii) 
rhizomes using chloroform led to the isolation and identification of CABE. CABE 
had been identified as the active component in V. wallichii rhizomes which is 
responsible for the treatment of Leishmaniasis, an infectious disease caused by 
protozoan parasites (Glaser et al., 2014). In most of previous studies, CABE was 
obtained directly from plant through the chemical extraction method. Alternatively, 
CABE can be synthesized from natural-based compounds such as caffeic acid, 
caffeic acid ester and borneol. Since the chemical structure of CAPE is similar to 
CABE, the previous researches on the synthesis of CAPE can be used as references 
for the improvement in CABE synthesis. The chemical structures of CABE and 
CAPE are as shown in Figure 1.2 (a) and (b), respectively. 
 
 
  
           (a)                                (b) 
Figure 1.2: (a) Caffeic acid bornyl ester, CABE (Yang et al., 2014); (b) Caffeic acid 
phenethyl ester, CAPE (Murtaza et al., 2014) 
 
 
 
